Clinical Trials on Mammographic Breast Density in Czechia
Total 168 results
-
Masaryk Memorial Cancer InstituteCompletedEarly-stage Breast CancerCzechia
-
The Institute of Molecular and Translational Medicine...University Hospital OlomoucRecruitingMetastatic Breast Cancer | Breast Neoplasm FemaleCzechia
-
Masaryk UniversityMasaryk Memorial Cancer InstituteRecruitingBreast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage IIICzechia
-
Carebot s.r.o.CompletedBreast Cancer | Breast Tumor BenignCzechia
-
Samsung Bioepis Co., Ltd.CompletedHER2 Positive Early or Locally Advanced Breast CancerCzechia
-
Czech Technical University in PragueCompletedEffect of Breast Tissue on EIT Lung MonitoringCzechia
-
University Hospital OstravaCompletedBreast Carcinoma | Breast Carcinoma Metastatic in Lymph NodeCzechia
-
University Hospital OstravaSilesian Hospital in OpavaCompletedBreast CancerCzechia
-
ImunonWithdrawnBreast CancerIsrael, Czechia, Italy
-
SanofiTerminatedTriple Negative Breast CancerSpain, Belgium, Italy, Czechia, Netherlands
-
University Hospital OstravaUniversity of Ostrava; Silesian Hospital in Opava; Masaryk Memorial Cancer Institute and other collaboratorsCompleted
-
Bulovka HospitalCompletedFatgrafting to a Breast After Breast Conserving TherapyCzech Republic
-
Rhizen Pharmaceuticals SACompletedSolid Tumor | Metastatic Breast Cancer | Locally Advanced Breast Cancer | Extensive-stage Small-cell Lung Cancer | Platinum-Sensitive Fallopian Tube Carcinoma | Platinum-sensitive Ovarian Cancer | Platinum-Sensitive Peritoneal CancerCzechia, Poland
-
IceCure Medical Ltd.Completed
-
Acrotech Biopharma Inc.CompletedBreast Cancer | Breast Tumors | Neoplasms, Breast | Cancer of the Breast | Human Mammary CarcinomaFrance, United States, Czechia, Hungary
-
AstraZenecaCompletedAdvanced Breast Cancer | Metastatic Breast CancerBelgium, Turkey, Canada, Poland, Romania, Hungary, France, Czechia
-
MedSIRCompletedMetastatic Breast CancerSpain, Czechia, France, Germany, Italy, Russian Federation, United Kingdom
-
AstraZenecaCompletedAdvanced Breast CancerRussian Federation, Ukraine, Czech Republic
-
Charles University, Czech RepublicRecruitingPneumonia | Cough | Asthma | Asthma in Children | Dyspnea | Recurrent Respiratory Tract Infections | Shortness of Breath | Wheezing | Mucus; Plug | Lower Respiratory Tract and Lung Infections | Chest TightnessCzechia
-
Daehwa Pharmaceutical Co., Ltd.CompletedRecurrent or Metastatic Breast CancerUnited States, Czechia
-
AstraZenecaCompletedMetastatic Breast CancerItaly, United Kingdom, Brazil, Czechia, Poland, United States, Spain, Bulgaria, France
-
AstraZenecaCompletedAdvanced or Metastatic Breast Cancer | ER+ve Advanced or Metastatic Breast CancerCanada, France, Korea, Republic of, Czechia, Peru, United Kingdom, Spain, Japan, Mexico, Singapore, Bulgaria
-
Syndax PharmaceuticalsCompletedBreast Cancer | ER+ Breast Cancer | Estrogen Receptor-Positive Breast Cancer | Breast Cancer, Estrogen Receptor-PositiveUnited States, Czechia, Canada, Hungary, Russian Federation
-
SanofiActive, not recruitingBreast CancerCzechia, Belgium, Spain, United States, France, Canada, Italy, Poland, Portugal, United Kingdom
-
Eli Lilly and CompanyCompletedBreast CancerAustria, Czech Republic, Hungary, Poland, Romania, Russian Federation
-
R-PharmCompletedMetastatic Breast Cancer | Triple Negative Locally Advanced Non-resectable Breast CancerCzech Republic, Italy, Poland, Spain, Austria, France, Greece
-
PfizerCompletedEarly Breast CancerCzechia, Serbia, Slovakia, United States, Belarus, Hungary, Ukraine, Italy, Poland, Russian Federation
-
Samsung Bioepis Co., Ltd.TerminatedBreast NeoplasmsUkraine, Romania, Russian Federation, France, Bulgaria, Czechia, Poland
-
Eli Lilly and CompanyActive, not recruitingMetastatic Breast CancerSpain, Taiwan, United States, Italy, Czechia, Germany, Belgium, Turkey, Brazil, Russian Federation, Argentina, Austria, France, Mexico
-
Central European Cooperative Oncology GroupCompletedBreast CancerBulgaria, Austria, Czech Republic, Israel, Lebanon, Poland, Slovakia
-
Central European Cooperative Oncology GroupCompletedMetastatic Breast CancerSerbia, Israel, Croatia, Hungary, Poland, Bosnia and Herzegovina, Latvia, Slovakia, Austria, Czechia, Bulgaria, Romania
-
AstraZenecaCompletedFGFR Inhibition, Pharmacokinetics, Biomarkers | ER+ Breast CancerCzech Republic, Italy, United Kingdom, Hungary, Germany, Romania, Belgium, France
-
Zeno Alpha Inc.CompletedBreast CancerUnited States, Belarus, Bosnia and Herzegovina, Czechia, Hungary, Lithuania, Russian Federation, Serbia, Ukraine
-
Dompé Farmaceutici S.p.APRA Health SciencesCompletedMetastatic Breast CancerUnited States, Spain, Belgium, Italy, France, Czechia, Poland
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedBreast CancerSpain, Poland, Italy, Austria, Russian Federation, Slovakia, Hungary, Germany, Czech Republic, Estonia, Latvia
-
Hoffmann-La RocheTerminatedBreast CancerIsrael, Italy, Spain, United States, Belgium, Czechia, Australia, United Kingdom, Korea, Republic of, Romania, France, Taiwan, Latvia
-
Hoffmann-La RocheActive, not recruitingTriple-Negative Breast CancerItaly, Portugal, Slovenia, Spain, Romania, France, Czechia, Peru, Argentina, Chile, Hungary, Mexico, Poland
-
Novartis PharmaceuticalsActive, not recruitingBreast CancerUnited States, South Africa, Austria, Hungary, Germany, Czechia, France, Russian Federation, Thailand, Belgium, Bulgaria, Lithuania, Jordan, Sweden, Finland, Peru, Colombia, Portugal, Canada, Brazil, India, Argentina, Costa Rica
-
Astellas Pharma IncCompletedBreast CancerUnited States, Ireland, Belgium, Czech Republic, Germany, Poland, Russian Federation, United Kingdom
-
Novartis PharmaceuticalsRecruitingBreast CancerGermany, Italy, Belgium, Denmark, France, Spain, Finland, Hungary, Ireland, Czechia, Greece, Canada, Portugal, Slovakia, Bulgaria, Poland, Romania
-
SanofiCancer International Research Group (CIRG)CompletedBreast CancerUnited States, France, Canada, Brazil, Poland, Germany, Portugal, Spain, Sweden, Slovakia, Czech Republic, Uruguay, Argentina, Egypt, Hungary, Israel, South Africa, Austria, Greece, United Kingdom
-
AstraZenecaCompletedBreast CancerCzech Republic
-
Bristol-Myers SquibbCompletedBreast CancerCzech Republic, United States, Spain, United Kingdom, Ireland, Poland, France, Sweden
-
AstraZenecaCompletedBreast CancerSweden, Czech Republic, France, Spain, United Kingdom, Hungary, Portugal
-
Hoffmann-La RocheRecruitingBreast CancerKorea, Republic of, United States, Israel, Denmark, Argentina, Mexico, Brazil, Germany, Peru, Poland, Spain, Taiwan, South Africa, Czechia, Italy, Australia, Hungary
-
PfizerRecruitingBreast Cancer | Solid TumorsChina, United States, Mexico, Bulgaria, Spain, Brazil, Czechia, Argentina, South Africa
-
Hoffmann-La RocheChugai PharmaceuticalCompletedBreast CancerKorea, Republic of, Canada, Brazil, Germany, Italy, Spain, Japan, Czechia, Poland, United States, Russian Federation, Taiwan
-
Novartis PharmaceuticalsTerminatedMelanoma | Head and Neck Cancer | Pancreatic Cancer | Urothelial Cancer | NSCLC, Non Small Cell Lung Cancer | RCC, Renal Cell Cancer | DLBCL, Diffused Large B Cell Lymphoma | MSS, Microsatellite Stable Colon Cancer | TNBC, Triple Negative Breast Cancer | mCRPC, Metastatic Castration Resistant Prostate...Belgium, Italy, Taiwan, Germany, Spain, United States, Argentina, Australia, Austria, Czechia, France, Japan, Netherlands, Switzerland, Singapore
-
Hoffmann-La RocheCompletedEarly Breast CancerFrance, Spain, United States, Korea, Republic of, Canada, United Kingdom, Argentina, Belgium, Germany, Italy, Taiwan, Thailand, Japan, Brazil, Mexico, Czechia, Poland, Russian Federation, Ukraine
-
AstraZenecaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Canada, Czechia, Poland, France, Korea, Republic of, Germany, Taiwan, Portugal, Netherlands, Ireland